Literature DB >> 27056398

Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.

Russell B Van Dyke1, Kunjal Patel2, Ron M Kagan3, Brad Karalius2, Shirley Traite4, William A Meyer5, Katherine K Tassiopoulos2, George R Seage2, Lorna M Seybolt6, Sandra Burchett7, Rohan Hazra8, Robert H Lurie, Ram Yogev, Margaret Ann Sanders, Kathleen Malee, Scott Hunter, William Shearer, Mary Paul, Norma Cooper, Lynnette Harris, Murli Purswani, Mahboobullah Baig, Anna Cintron, Ana Puga, Sandra Navarro, Patricia Garvie, James Blood, Sandra Burchett7, Nancy Karthas, Betsy Kammerer, Andrew Wiznia, Marlene Burey, Molly Nozyce, Arry Dieudonne, Linda Bettica, Susan Adubato, Janet Chen, Maria Garcia Bulkley, Latreaca Ivey, Mitzie Grant, Katherine Knapp, Kim Allison, Megan Wilkins, Midnela Acevedo-Flores, Heida Rios, Vivian Olivera, Margarita Silio, Medea Jones, Patricia Sirois, Stephen Spector, Kim Norris, Sharon Nichols, Elizabeth McFarland, Alisa Katai, Jennifer Dunn, Suzanne Paul, Gwendolyn Scott, Patricia Bryan, Elizabeth Willen.   

Abstract

Among 234 US youths with perinatal human immunodeficiency virus, 75% had antiretroviral resistance, substantially higher than that of the reference laboratory overall (36%-44%). Resistance to newer antiretrovirals and to all antiretrovirals in a class was uncommon. The only factor independently associated with future resistance was a higher peak viral load.
© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  adolescents; antiviral resistance; children; human immunodeficiency virus; perinatal infection

Mesh：

Substances：

Year:  2016        PMID： 27056398      PMCID： PMC4901868          DOI： 10.1093/cid/ciw213

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  12 in total

1.  HIV-1 phenotypic drug resistance testing among highly treatment experienced and poorly adherent youth.

Authors:  Walter Dehority; Jaime G Deville; Jorge-Lujan Zilbermann; Rolando M Viani
Journal:  Pediatr Infect Dis J       Date:  2013-10       Impact factor: 2.129

2.  Relationship between viral load and self-report measures of medication adherence among youth with perinatal HIV infection.

Authors:  Ann Usitalo; Erin Leister; Katherine Tassiopoulos; Susannah Allison; Kathleen Malee; Mary E Paul; Renee Smith; Russell B Van Dyke; George R Seage; Claude A Mellins
Journal:  AIDS Care       Date:  2013-06-26

3.  Trends in drug resistance prevalence in HIV-1-infected children in Madrid: 1993 to 2010 analysis.

Authors:  Miguel de Mulder; Gonzalo Yebra; Adriana Navas; Leticia Martin; Maria Isabel de Jose; Maria Luisa Navarro; Santiago Jimenez de Ory; Ignacio Gonzalez-Granado; Maria Jose Mellado; Jose Tomas Ramos; Africa Holguin
Journal:  Pediatr Infect Dis J       Date:  2012-11       Impact factor: 2.129

4.  Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes.

Authors:  Russell B Van Dyke; Kunjal Patel; George K Siberry; Sandra K Burchett; Stephen A Spector; Miriam C Chernoff; Jennifer S Read; Lynne M Mofenson; George R Seage
Journal:  J Acquir Immune Defic Syndr       Date:  2011-06-01       Impact factor: 3.731

Review 5.  Relationship between minority nonnucleoside reverse transcriptase inhibitor resistance mutations, adherence, and the risk of virologic failure.

Authors:  Jonathan Z Li; Roger Paredes; Heather J Ribaudo; Evguenia S Svarovskaia; Michael J Kozal; Katherine H Hullsiek; Michael D Miller; David R Bangsberg; Daniel R Kuritzkes
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

6.  Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates.

Authors:  David R Bangsberg; Travis C Porco; C Kagay; Edwin D Charlebois; Steven G Deeks; David Guzman; Richard Clark; Andrew Moss
Journal:  J Infect Dis       Date:  2004-06-09       Impact factor: 5.226

7.  Antiretroviral medication adherence and class- specific resistance in a large prospective clinical trial.

Authors:  Edward M Gardner; Katherine H Hullsiek; Edward E Telzak; Shweta Sharma; Grace Peng; William J Burman; Rodger D MacArthur; Margaret Chesney; Gerald Friedland; Sharon B Mannheimer
Journal:  AIDS       Date:  2010-01-28       Impact factor: 4.177

8.  Initiation of HAART at higher CD4 cell counts is associated with a lower frequency of antiretroviral drug resistance mutations at virologic failure.

Authors:  Jonathan Uy; Carl Armon; Kate Buchacz; Kathy Wood; John T Brooks
Journal:  J Acquir Immune Defic Syndr       Date:  2009-08-01       Impact factor: 3.731

9.  Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure.

Authors:  Roger Paredes; Christina M Lalama; Heather J Ribaudo; Bruce R Schackman; Cecilia Shikuma; Francoise Giguel; William A Meyer; Victoria A Johnson; Susan A Fiscus; Richard T D'Aquila; Roy M Gulick; Daniel R Kuritzkes
Journal:  J Infect Dis       Date:  2010-03       Impact factor: 5.226

10.  Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.

Authors:  Robert S Hogg; David R Bangsberg; Viviane D Lima; Chris Alexander; Simon Bonner; Benita Yip; Evan Wood; Winnie W Y Dong; Julio S G Montaner; P Richard Harrigan
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069
View more
  16 in total

1.  Trends in post-partum viral load among women living with perinatal HIV infection in the USA: a prospective cohort study.

Authors:  Kunjal Patel; Brad Karalius; Kathleen Powis; Deborah Kacanek; Claire Berman; Anna-Barbara Moscicki; Mary Paul; Katherine Tassiopoulos; George R Seage
Journal:  Lancet HIV       Date:  2019-12-20       Impact factor: 12.767

2.  Old Problems for New Providers: Managing the Postpediatric HIV Generation.

Authors:  Annette H Sohn; Rohan Hazra
Journal:  Clin Infect Dis       Date:  2017-04-15       Impact factor: 9.079

3.  Brain and Cognitive Development Among U.S. Youth With Perinatally Acquired Human Immunodeficiency Virus Infection.

Authors:  Kathleen M Malee; Renee A Smith; Claude A Mellins
Journal:  J Pediatric Infect Dis Soc       Date:  2016-12       Impact factor: 3.164

4.  Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.

Authors:  Anne M Neilan; Brad Karalius; Kunjal Patel; Russell B Van Dyke; Mark J Abzug; Allison L Agwu; Paige L Williams; Murli Purswani; Deborah Kacanek; James M Oleske; Sandra K Burchett; Andrew Wiznia; Miriam Chernoff; George R Seage; Andrea L Ciaranello
Journal:  JAMA Pediatr       Date:  2017-05-01       Impact factor: 16.193

5.  Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.

Authors:  George K Siberry; Anouk Amzel; Artur Ramos; Emilia D Rivadeneira
Journal:  J Infect Dis       Date:  2017-12-01       Impact factor: 5.226

6.  Nonadherence and unsuppressed viral load across adolescence among US youth with perinatally acquired HIV.

Authors:  Deborah Kacanek; Yanling Huo; Kathleen Malee; Claude A Mellins; Renee Smith; Patricia A Garvie; Katherine Tassiopoulos; Sonia Lee; Claire A Berman; Mary Paul; Ana Puga; Susannah Allison
Journal:  AIDS       Date:  2019-10-01       Impact factor: 4.177

7.  CHAMP+ Thailand: Pilot Randomized Control Trial of a Family-Based Psychosocial Intervention for Perinatally HIV-Infected Early Adolescents.

Authors:  Danielle Friedman Nestadt; Chutima Saisaengjan; Mary McKernan McKay; Torsak Bunupuradah; Gisselle Pardo; Sudrak Lakhonpon; Priya Gopalan; Cheng-Shiun Leu; Witaya Petdachai; Pope Kosalaraksa; Ussanee Srirompotong; Jintanat Ananworanich; Claude Ann Mellins
Journal:  AIDS Patient Care STDS       Date:  2019-05       Impact factor: 5.078

8.  Is There a Higher Risk of Mother-to-child Transmission of HIV Among Pregnant Women With Perinatal HIV Infection?

Authors:  Christopher J Goodenough; Kunjal Patel; Russell B Van Dyke
Journal:  Pediatr Infect Dis J       Date:  2018-12       Impact factor: 2.129

9.  Clinical Status of Adolescents with Perinatal HIV at Transfer to Adult Care in the UK/Ireland.

Authors:  Intira Jeannie Collins; Caroline Foster; Anna Tostevin; Pat Tookey; Andrew Riordan; David Dunn; D M Gibb; Ali Judd
Journal:  Clin Infect Dis       Date:  2017-04-15       Impact factor: 9.079

10.  Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol.

Authors:  Jennifer Jao; Deborah Kacanek; Paige L Williams; Mitchell E Geffner; Elizabeth G Livingston; Rhoda S Sperling; Kunjal Patel; Arlene D Bardeguez; Sandra K Burchett; Nahida Chakhtoura; Gwendolyn B Scott; Russell B Van Dyke; Elaine J Abrams
Journal:  Clin Infect Dis       Date:  2017-09-15       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.